Navigation Links
FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting
Date:3/2/2008

SA

HELSINN HEALTHCARE SA is a privately owned pharmaceutical group with headquarters in Switzerland and is the worldwide licensor of palonosetron. HELSINN's core business is the licensing of pharmaceuticals in therapeutic niche areas. The company's business strategy is to in-license early stage new chemical entities and complete their development from the performance of pre- clinical/clinical studies and CMC development to the attainment of market approvals in strategic markets (U.S. and Europe). HELSINN's products are eventually out-licensed to its marketing partners for distribution. The active pharmaceutical ingredients and the finished dosage forms are manufactured at HELSINN's cGMP facilities and supplied worldwide to its customers. For more information about HELSINN, please visit the company's Web site at http://www.helsinn.com.

About Eisai Corporation of North America

Eisai Corporation of North America is a wholly-owned subsidiary of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Eisai focuses its efforts in three therapeutic areas: neurology, gastrointestinal disorders and oncology/critical care.

Eisai Corporation of North America supports the activities of its operating companies in North America. These operating companies include: Eisai Research Institute of Boston, Inc., a discovery operation with strong organic chemistry capabilities; Morphotek, Inc., a biopharmaceutical company specializing in the development of therapeutic monoclonal antibodies; Eisai Medical Research Inc., a clinical development group; Eisai Inc., a commercial operation with manufacturing and marketing/sales functions; MGI PHARMA, INC.; and Eisai Machinery U.S.A., which markets and maintains pharmaceutical manufacturing machinery. For more information about Eisai, please visit '/>"/>

SOURCE Eisai Corporation of North America
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. FDA Approves Luvox(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
2. FDA Approves NEXIUM(R) for the Treatment of Short-Term GERD in Children 1 to 11 Years Old
3. U.S. Court Approves AK Steels VEBA Health Care Settlement With Middletown Works Retirees
4. Securian Board Approves 8 Officer Promotions
5. MGT Capital Investments, Inc. Approves Share Buyback Program
6. Kaiser Permanente Approves $29 Million in Community Benefit Grants
7. Otter Tail Corporation Reports Record Revenues and Net Income From Continuing Operations for 2007; Earnings Per Share of $1.78; Board Approves Dividend Increase
8. Pennsylvania Attorney General Approves Vincentian Collaborative System-Marian Manor Integration
9. FDA Approves ASMANEX (R) TWISTHALER(R) (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11
10. FDA Approves Additional Indication for Astellas MYCAMINE(R)
11. FDA Approves Labeling Change for Non-Drowsy CLARITIN(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... Recently, Fadhits.com, the distinguished wedding dress manufacturer ... promotion. According to the company’s senior spokesman, the ... All the company’s current and prospective customers can get ... end of July. , Fadhits.com is a well-known ... customers. The company has its own designers who can ...
(Date:7/13/2014)... 2014 Worldwide ladies are extremely responsive ... has taken a different approach and has created a ... offered in more colour choices that responded directly to ... of women’s special occasion apparels. The company’s pink bridesmaid ... are working hard to create the best products for ...
(Date:7/13/2014)... to get the best treatment and variations in the ... survival for blood cancer patients still varies widely between ... of survival in European adults to date, published in ... is that 5-year survival for most cancers of the ... likely reflecting the approval of new targeted drugs in ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 Intraocular Lens ... and Forecast 2013 - 2019 , Intraocular lens (IOL) ... from myopia or cataracts. The lenses are inserted inside ... cataract surgery intraocular lens replaces the focusing power of ... original crystalline lens to deliver the light focusing function ...
(Date:7/13/2014)... Chromatography system is a physical method ... of biological samples such as air and water. ... two phase, namely mobile phase and stationary phase. ... the stationary phase, followed by the differential rate ... separation of mixture. Chromatography system plays an important ...
Breaking Medicine News(10 mins):Health News:Fashionable Pageant Dresses Now On Sale At Fadhits.com 2Health News:Angeldress.co.uk Announces Summer Sale For Pink And Red Bridesmaid Dresses; The Current Discount Is Up To 80% Off 2Health News:The Lancet Oncology: Differences in treatment likely to be behind differing survival rates for blood cancers between regions within Europe 2Health News:The Lancet Oncology: Differences in treatment likely to be behind differing survival rates for blood cancers between regions within Europe 3Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Health News:North America Chromatography Systems Market Is Expected to Reach $6593.4 Million by 2018 - New Report by MicroMarket Monitor 2Health News:North America Chromatography Systems Market Is Expected to Reach $6593.4 Million by 2018 - New Report by MicroMarket Monitor 3
... , , , ... With the return of busy school schedules combined ... back-to-basics when it comes to keeping on-the-go families fit and ... trainer, Valerie Waters, have teamed up to create simple solutions ...
... , NEW YORK, Sept. 2 The Prix Galien USA ... D. Sachs, Ph.D., of Columbia University with its 2009 Pro Bono Humanum ... the poorest corners of the globe. , , ... science and economics to global health problems in ways that have changed ...
... , ANN ARBOR, Mich., Sept. ... Commission Strategic Surveillance System (S3) scores through a quality improvement program ... , , Rush-Copley,s efforts were built upon an ... order entry (CPOE) system. , , Following an ...
... , , SAN BERNARDINO, ... stay healthy and well by once again offering seasonal flu ... 17 and run through November 1 at most Stater Bros. ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20030421/STATERLOGO ) , , ...
... , , , , ... Zix Corporation (ZixCorp(R)), (Nasdaq: ZIXI ), the leader in ... This latest agreement is a two-year extension of Humana,s original agreement ... expands the number of ZixCorp licenses bringing the total to 36,000. ...
... Cancer Center has received an $8 million grant from ... Institutes of Health (NCRR/NIH) to expand their laboratory animal ... advanced research into the fundamental biological processes underlying cancer, ... The funds for the grant were made available through ...
Cached Medicine News:Health News:Celebrity Fitness Trainer Valerie Waters Offers On-the-Go Families Back-to-Basics Tips 2Health News:Celebrity Fitness Trainer Valerie Waters Offers On-the-Go Families Back-to-Basics Tips 3Health News:Celebrity Fitness Trainer Valerie Waters Offers On-the-Go Families Back-to-Basics Tips 4Health News:Barry Bloom, Jeffrey Sachs to Be Honored for Introducing Modern Solutions to The World's Oldest Problems: Poverty And Disease 2Health News:Rush-Copley Medical Center Uses Thomson Reuters Order Sets Solution to Improve Joint Commission S3 Scores 2Health News:Rush-Copley Medical Center Uses Thomson Reuters Order Sets Solution to Improve Joint Commission S3 Scores 3Health News:Stater Bros. Helps Customers Fight the Flu 2Health News:Zix Corporation and Humana Renew and Expand Exclusive Agreement 2Health News:Fox Chase Cancer Center receives $8 million NIH grant to expand laboratory animal research facility 2
(Date:7/10/2014)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... the sale to Galderma of all rights to Restylane, ... Valeant for $1.4 billion in cash, pursuant to the ... its acquisition of Galderma. "We are ... a company that is firmly committed to the aesthetic ...
(Date:7/10/2014)... -- Decision Resources Group finds that over half of ... Drug Administration,s (FDA) approval of Vifor Fresenius Medical Care ... by the FDA in November 2013 for the treatment ... dialysis. Other key findings from the report ... : , Bundling: Based ...
(Date:1/15/2014)... As health officials across the Midwest warn against the ... Michigan will offer free diagnostic testing ... pharmacists to administer tests and, in some cases, fill the ... in the study. The Grand Rapids, ...
Breaking Medicine Technology:Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3
... March 16, 2012 Obesity appears to significantly increase the ... rate of mortality even among those prescribed 18 or fewer ... emerged as a marker of increased vulnerability," said Robert ... Epidemiology and Prevention | Nutrition, Physical Activity and Metabolism 2012 ...
... 50th anniversary of Poison Prevention Week , March 18-24, ... pet owners that accidental poisonings are a common problem. ... in the home, and that,s true of pets as well.  ... household items are hazardous to pets.  The AVMA online ...
Cached Medicine Technology:Obesity Raises Death Risk Tied To Sleeping Pills 2Obesity Raises Death Risk Tied To Sleeping Pills 3Obesity Raises Death Risk Tied To Sleeping Pills 4Don't Give Your Pet a Deadly Dose; Medicines Top the List of Household Poisons for Pets 2
... Saturated Swabsticks are packaged ... foil-laminated pouches. Each 4 ... with precisely the correct ... package is terminally sterilized, ...
... alcohol and 10% povidone iodine formulated ... a barrier on the skin. The ... the povidone iodine, giving persistent protection ... catheter related infections for up to ...
... Aplicare's Saturated Swabsticks ... open, single-use foil-laminated pouches. ... is saturated with precisely ... solution. Each package is ...
... Aplicare's saturated swabsticks are packaged in easy ... inch swabstick is saturated with precisely the ... Gel Swabstick is saturated with a multi-purpose ... gel is also approved for venipuncture site ...
Medicine Products: